-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JWp0Wzds/9ZIDSFQ7FEUVaDmrG/jE4t/erAac/RXQEtx8O+AhY8waiDhWY9jRueN W384wMvTzILe1kL1HI54iw== 0001411920-10-000003.txt : 20100611 0001411920-10-000003.hdr.sgml : 20100611 20100611170030 ACCESSION NUMBER: 0001411920-10-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100611 DATE AS OF CHANGE: 20100611 EFFECTIVENESS DATE: 20100611 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IRX Therapeutics, Inc. CENTRAL INDEX KEY: 0001411920 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-143398 FILM NUMBER: 10893038 BUSINESS ADDRESS: STREET 1: 140 W 57th St STREET 2: SUITE 9C CITY: New York STATE: NY ZIP: 10019 BUSINESS PHONE: 212-582-1199 MAIL ADDRESS: STREET 1: 140 W 57th St STREET 2: SUITE 9C CITY: New York STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: IRX Therapeutics Inc DATE OF NAME CHANGE: 20070910 D 1 primary_doc.xml X0704 D LIVE 0001411920 IRX Therapeutics, Inc. 140 W. 57th St. SUITE 9C New York NY NEW YORK 10019 212 582-1199 DELAWARE IRX Therapeutics Inc Corporation true Jeffrey Hwang c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 9C New York NY NEW YORK 10019 Executive Officer John W. Hadden c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 9C New York NY NEW YORK 10019 Director John W. Hadden II c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 9C New York NY NEW YORK 10019 Executive Officer Ferid Murad c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 9C New York NY NEW YORK 10019 Director John T. Spitznagel c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 9C New York NY NEW YORK 10019 Director Howard H. Stevenson c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 9C New York NY NEW YORK 10019 Director Lawrence M. Wolf c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 9C New York NY NEW YORK 10019 Director Frank J. Loverro c/o IRX Therapeutics, Inc. 140 W. 57th St., Suite 9C New York NY NEW YORK 10019 Director Biotechnology No Revenues 06 false 2010-05-28 false true true false 0 Indefinite 8047991 Indefinite false 163 0 0 400000 true false IRX Therapeutics, Inc. /s/ JEFFREY HWANG Jeffrey Hwang CFO 2010-06-11 -----END PRIVACY-ENHANCED MESSAGE-----